Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q2 2016 · 10-Q
Revenue$134.00K$134.00K−63.5% vs Q2 2015 Net Income-$2.25M-$2.25MN/M vs Q2 2015 EPS Diluted-$0.03-$0.03N/M vs Q2 2015 Operating Income-$2,254,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,672,000N/M Margins · derivedOperating margin-1682.1%−1228.1 pt vs Q2 2015
Net margin-1676.1%−1225.7 pt vs Q2 2015
ended Dec 31, 2015 · filed Feb 22, 2016 · 53 d after period end